205 related articles for article (PubMed ID: 25724134)
21. Controlling silk fibroin particle features for drug delivery.
Lammel AS; Hu X; Park SH; Kaplan DL; Scheibel TR
Biomaterials; 2010 Jun; 31(16):4583-91. PubMed ID: 20219241
[TBL] [Abstract][Full Text] [Related]
22. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
[TBL] [Abstract][Full Text] [Related]
23. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
24. A novel heparin release system based on blends of biomedical polyurethane and native silk fibroin powder.
Yang H; Xu H; Liu H; Ouyang C; Xu W
J Control Release; 2011 Nov; 152 Suppl 1():e106-8. PubMed ID: 22195783
[No Abstract] [Full Text] [Related]
25. Sustained Release of Insulin-Like Growth Factor-1 from
Lin MJ; Lu MC; Chang HY
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200896
[TBL] [Abstract][Full Text] [Related]
26. Endothelin-1 inhibits size dependent lymphatic clearance of PEG-based conjugates after intra-articular injection into the rat knee.
Doan TN; Bernard FC; McKinney JM; Dixon JB; Willett NJ
Acta Biomater; 2019 Jul; 93():270-281. PubMed ID: 30986528
[TBL] [Abstract][Full Text] [Related]
27. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery.
Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B
ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601
[TBL] [Abstract][Full Text] [Related]
28. Regenerated silk fibroin films with controllable nanostructure size and secondary structure for drug delivery.
Zhou J; Zhang B; Shi L; Zhong J; Zhu J; Yan J; Wang P; Cao C; He D
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21813-21. PubMed ID: 25536875
[TBL] [Abstract][Full Text] [Related]
29. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
[TBL] [Abstract][Full Text] [Related]
30. Characterization of silk fibroin-based microneedles and in vitro study of stromal cell-derived factor-1-loaded microneedles on adipose stem cell recruitment.
Chen WX; Cheng NC; Chen YJ; Lee IC
Int J Biol Macromol; 2023 Apr; 233():123537. PubMed ID: 36740118
[TBL] [Abstract][Full Text] [Related]
31. Silk fibroin as an organic polymer for controlled drug delivery.
Hofmann S; Foo CT; Rossetti F; Textor M; Vunjak-Novakovic G; Kaplan DL; Merkle HP; Meinel L
J Control Release; 2006 Mar; 111(1-2):219-27. PubMed ID: 16458987
[TBL] [Abstract][Full Text] [Related]
32. Structural insights into pH-responsive drug release of self-assembling human serum albumin-silk fibroin nanocapsules.
Tallian C; Herrero-Rollett A; Stadler K; Vielnascher R; Wieland K; Weihs AM; Pellis A; Teuschl AH; Lendl B; Amenitsch H; Guebitz GM
Eur J Pharm Biopharm; 2018 Dec; 133():176-187. PubMed ID: 30291964
[TBL] [Abstract][Full Text] [Related]
33. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system.
Akrami-Hasan-Kohal M; Eskandari M; Solouk A
Colloids Surf B Biointerfaces; 2021 Sep; 205():111892. PubMed ID: 34107443
[TBL] [Abstract][Full Text] [Related]
34. Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice.
Pradal J; Maudens P; Gabay C; Seemayer CA; Jordan O; Allémann E
Int J Pharm; 2016 Feb; 498(1-2):119-29. PubMed ID: 26685724
[TBL] [Abstract][Full Text] [Related]
35. Development of nanoparticles-in-microparticles system for improved local retention after intra-articular injection.
Chen Z; Liu D; Wang J; Wu L; Li W; Chen J; Cai BC; Cheng H
Drug Deliv; 2014 Aug; 21(5):342-50. PubMed ID: 24215110
[TBL] [Abstract][Full Text] [Related]
36. Modulation of vincristine and doxorubicin binding and release from silk films.
Coburn JM; Na E; Kaplan DL
J Control Release; 2015 Dec; 220(Pt A):229-238. PubMed ID: 26500149
[TBL] [Abstract][Full Text] [Related]
37. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
38. Transdermal delivery of 40-nm silk fibroin nanoparticles.
Takeuchi I; Shimamura Y; Kakami Y; Kameda T; Hattori K; Miura S; Shirai H; Okumura M; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2019 Mar; 175():564-568. PubMed ID: 30579057
[TBL] [Abstract][Full Text] [Related]
39. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
40. Intra-articular lornoxicam loaded PLGA microspheres: enhanced therapeutic efficiency and decreased systemic toxicity in the treatment of osteoarthritis.
Zhang Z; Huang G
Drug Deliv; 2012; 19(5):255-63. PubMed ID: 22775466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
